BioMarin Pharmaceutical (BMRN) said Friday it will acquire Amicus Therapeutics (FOLD) for $4.8 billion in a deal that adds two rare disease drugs to its portfolio. In premarket trades on the stock market today, Amicus stock catapulted 29.8% to 14.13, just under the takeover price of $14.50 per share. The biotech stock is highly rated and has climbed roughly 94%…
Nvidia (NASDAQ: NVDA) is the poster child for the artificial intelligence (AI) industry. Its chips are the "brains" that make...
Federal immigration agents newly ordered to U.S. airports by President Donald Trump to help relieve security line congestion may guard exit lanes...
The past several weeks have been challenging ones for the overall market. But they've been downright miserable ones for most...
The Strait of Hormuz crisis is exposing an unpleasant truth: the global economy is still very dependent on oil,...
Cuba began restoring its energy system on Sunday, a day after a nationwide collapse of the entire grid left millions of people...
The share price of UAV company Aerodrome Group (TASE: ARDM) has risen sharply in recent weeks following the announcement...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
